propranolol has been researched along with aminopyrine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (50.00) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 7 (29.17) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, G; Ermondi, G | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Baert, B; Beetens, J; Bodé, S; De Spiegeleer, B; Deconinck, E; Lambert, J; Slegers, G; Slodicka, M; Stoppie, P; Van Gele, M; Vander Heyden, Y | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Akamatsu, M | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Honda, K; Izumi, T; Miyaji, Y; Nakayama, S; Okazaki, O; Okudaira, N; Shiosakai, K; Sugiyama, D; Suzuki, W; Takakusa, H; Watanabe, A | 1 |
| Barber, S; Dew, TP; Farrell, TL; Poquet, L; Williamson, G | 1 |
| Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
| Branch, RA; Gerber, JG; Shand, DG; Villeneuve, JP; Wilson, JT | 1 |
| Arganese, T; Blackman, F; Lindsey, D; Parker, DA; Ushman, D; Werstlein, T | 1 |
| Baba, S; Goromaru, T | 1 |
| Branch, RA; Rogers, L; Shand, DG; Villeneuve, JP; Wood, AJ | 1 |
| Ankermann, H; Klinger, W; Müller, D | 1 |
| Humphries, TJ | 1 |
| Cockrill, BL; Platt, DS | 1 |
| Topham, JC | 1 |
| Helfer, H; Jaques, R | 1 |
| Jaques, R; Riesterer, L | 2 |
| Ankermann, H; Grübner, I; Klinger, W | 1 |
| Vesell, ES | 1 |
2 review(s) available for propranolol and aminopyrine
| Article | Year |
|---|---|
Clinical implications of drug interactions with the cytochrome P-450 enzyme system associated with omeprazole.
Topics: Aminopyrine; Animals; Antipyrine; Cytochrome P-450 Enzyme System; Diazepam; Drug Interactions; Humans; Omeprazole; Phenytoin; Propranolol; Theophylline; Warfarin | 1991 |
Noninvasive assessment in vivo of hepatic drug metabolism in health and disease.
Topics: Adult; Aminopyrine; Animals; Antipyrine; Breath Tests; Humans; Liver; Liver Cirrhosis; Liver Diseases; Liver Function Tests; Male; Mixed Function Oxygenases; Pharmaceutical Preparations; Propranolol; Rats; Saliva | 1984 |
22 other study(ies) available for propranolol and aminopyrine
| Article | Year |
|---|---|
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
Transdermal penetration behaviour of drugs: CART-clustering, QSPR and selection of model compounds.
Topics: Anti-Inflammatory Agents; Cell Membrane Permeability; Cluster Analysis; Drug Evaluation, Preclinical; Humans; Models, Biological; Predictive Value of Tests; Quantitative Structure-Activity Relationship; Regression Analysis; Skin; Skin Absorption | 2007 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Combination of GSH trapping and time-dependent inhibition assays as a predictive method of drugs generating highly reactive metabolites.
Topics: Glutathione; Pharmacology; Sulfur Radioisotopes | 2011 |
Predicting phenolic acid absorption in Caco-2 cells: a theoretical permeability model and mechanistic study.
Topics: Artificial Intelligence; Caco-2 Cells; Cell Membrane Permeability; Cinnamates; Enterocytes; Humans; Hydrophobic and Hydrophilic Interactions; Intestinal Absorption; Kinetics; Models, Biological; Molecular Conformation; Osmolar Concentration; Phenols | 2012 |
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
Drug metabolism in rats bearing a pituitary mammotropic tumor.
Topics: Aminopyrine; Animals; Antipyrine; Cardiac Output; Half-Life; Liver; Male; Mammary Glands, Animal; Neoplasms, Experimental; Pharmaceutical Preparations; Pituitary Neoplasms; Propranolol; Rats; Rats, Inbred F344; Regional Blood Flow | 1979 |
Modification by dipyrone (noramidopyrine methanesulphonate) of stone-induced ureteric hyperperistalsis in the dog.
Topics: Aminopyrine; Animals; Dipyrone; Dogs; Epinephrine; Isoproterenol; Muscle Contraction; Norepinephrine; Parasympatholytics; Phenoxybenzamine; Propranolol; Ureter; Ureteral Calculi | 1979 |
[Utilization of stable isotopes in the life sciences].
Topics: Aminopyrine; Animals; Body Composition; Body Water; Breath Tests; Carbon Isotopes; Chlorpheniramine; Deuterium; Humans; Isoniazid; Isotopes; Magnetic Resonance Spectroscopy; Mass Spectrometry; Nitrogen Isotopes; Oxygen Isotopes; Piperazines; Propranolol; Stereoisomerism | 1978 |
Impaired drug metabolism in experimental cirrhosis in the rat.
Topics: Aminopyrine; Animals; Half-Life; Hexobarbital; Kinetics; Liver; Liver Cirrhosis, Experimental; Male; Pharmaceutical Preparations; Propranolol; Rats | 1978 |
[The effect of symphathicotropic substances on liver microsomes in vivo and in vitro].
Topics: Aminopyrine; Animals; Dihydroergotamine; Ephedrine; Hexobarbital; In Vitro Techniques; Male; Microsomes, Liver; p-Dimethylaminoazobenzene; Propranolol; Rats; Sympatholytics; Sympathomimetics | 1975 |
Biochemical changes in rat liver in response to treatment with drugs and other agents. I. Effects of anticonvulsant, anti-inflammatory, hypocholesterolaemic and adrenergic beta-blocking agents.
Topics: Acetanilides; Aminopyrine; Animals; Anti-Inflammatory Agents; Anticholesteremic Agents; Anticonvulsants; Barbiturates; Body Weight; Butyrates; Cytochromes; Cytoplasm; Electron Transport; Glucose-6-Phosphatase; Glucosephosphate Dehydrogenase; Glutamate Dehydrogenase; Indomethacin; L-Lactate Dehydrogenase; Liver; Male; Microsomes; Organ Size; Oxidoreductases; Phenobarbital; Phenylbutazone; Phenytoin; Phosphogluconate Dehydrogenase; Propranolol; Proteins; Rats; Sympatholytics | 1969 |
Relationship between difference spectra and metabolism. Barbiturates, drug interaction and species difference.
Topics: Acetanilides; Acetates; Amino Alcohols; Aminopyrine; Aniline Compounds; Animals; Barbiturates; Binding Sites; Chemical Phenomena; Chemistry; Chlorpromazine; Cytochromes; Drug Antagonism; Drug Synergism; Ethanolamines; Hexobarbital; Macaca; Male; Mice; Microsomes, Liver; Pentobarbital; Phenobarbital; Proadifen; Propranolol; Protein Binding; Rats; Sleep; Species Specificity; Spectrophotometry; Thiazoles; Tremorine | 1970 |
Modification of the antinociceptive action of aminopyrine by an -adrenergic blocking agent (phentolamine) and 2 -adrenergic blocking drugs (propranolol, oxoprenolol).
Topics: 1-Propanol; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Aminopyrine; Animals; Arachidonic Acids; Drug Synergism; Male; Mice; Phentolamine; Propranolol; Propylamines; Spasm | 1971 |
The influence of anti-inflammatory drugs on the development of an experimental traumatic paw oedema in the rat.
Topics: Adrenal Glands; Adrenalectomy; Aminopyrine; Animals; Anti-Inflammatory Agents; Bromelains; Edema; Furans; Glycosides; Hindlimb; Hydrocortisone; Male; Phenylbutazone; Propranolol; Rats; Rutin; Salicylates; Sodium; Time Factors | 1970 |
[Various substances and substance classes with inductive properties. I. Aminoketones and aminoalcohols].
Topics: Amino Alcohols; Aminopyrine; Animals; Ascorbic Acid; Dealkylation; Hexobarbital; Ketones; Male; Propranolol; Rats; Sleep; Triazoles | 1971 |
Interference, by beta-adrenergic blocking agents, with the anti-inflammatory action of various drugs.
Topics: Aminopyrine; Animals; Anti-Inflammatory Agents; Depression, Chemical; Exudates and Transudates; Hydrocortisone; Male; Phenylbutazone; Pleurisy; Propranolol; Rats; Sodium Salicylate; Sympatholytics; Turpentine | 1968 |